Insider Transactions in Q2 2022 at Teva Pharmaceutical Industries LTD (TEVA)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 14
2022
|
Sol J Barer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,791
+6.99%
|
-
|
|
Jun 14
2022
|
Rosemary A Crane |
BUY
Exercise of conversion of derivative security
|
Direct |
14,479
+17.84%
|
-
|
|
Jun 14
2022
|
Amir Elstein |
BUY
Exercise of conversion of derivative security
|
Direct |
14,479
+0.7%
|
-
|
|
Jun 14
2022
|
Jean Michel Halfon Director |
BUY
Exercise of conversion of derivative security
|
Direct |
14,479
+18.52%
|
-
|
|
Jun 14
2022
|
Gerald M Lieberman |
BUY
Exercise of conversion of derivative security
|
Direct |
14,479
+17.32%
|
-
|
|
Jun 14
2022
|
Roberto Mignone |
BUY
Exercise of conversion of derivative security
|
Direct |
14,479
+19.77%
|
-
|
|
Jun 14
2022
|
Perry Nisen |
BUY
Exercise of conversion of derivative security
|
Direct |
14,479
+19.77%
|
-
|
|
Jun 14
2022
|
Nechemia Jacob Peres Director |
BUY
Exercise of conversion of derivative security
|
Direct |
14,479
+19.77%
|
-
|
|
Jun 14
2022
|
Ronit Satchi Fainaro |
BUY
Exercise of conversion of derivative security
|
Direct |
14,479
+21.99%
|
-
|
|
Jun 14
2022
|
Janet S. Vergis |
BUY
Exercise of conversion of derivative security
|
Direct |
14,479
+34.78%
|
-
|
|
May 17
2022
|
Hafrun Fridriksdottir Executive VP, Global R&D |
SELL
Open market or private sale
|
Direct |
130,000
-98.95%
|
$1,040,000
$8.22 P/Share
|